5-methylcytosine has been researched along with Melanoma in 23 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (8.70) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (4.35) | 29.6817 |
2010's | 18 (78.26) | 24.3611 |
2020's | 2 (8.70) | 2.80 |
Authors | Studies |
---|---|
Gruis, N; Janssen, B; Kumar, R; Oosting, J; Salgado, C; van Doorn, R | 1 |
Balzer, BL; Frishberg, DP; Shon, W; Yagi, S | 1 |
Barciszewska, AM | 1 |
Balzer, BL; Essner, R; Frishberg, DP; Huynh, CAT; Shon, W; Siref, AB | 1 |
Chen, Y; Sugiyama, T | 1 |
Gambichler, T; Sand, M; Skrygan, M | 1 |
Ashida, A; Hayashi, K; Kiniwa, Y; Koga, H; Ogawa, E; Okuyama, R; Takazawa, Y; Uchiyama, A; Uchiyama, R; Uhara, H | 1 |
Adany, R; Balazs, M; Ecsedi, SI; Herceg, Z; Hernandez-Vargas, H; Lima, SC | 1 |
Dresser, KA; Larson, AR; Lezcano, C; Lian, CG; Mihm, MC; Murphy, GF; Scolyer, RA; Shi, YG; Thompson, JF; Woda, BA; Yosufi, B; Zhan, Q | 1 |
Granter, SR; Guo, W; Laga, AC; Lee, JJ; Lian, CG; Murphy, GF; Saavedra, AP; Xu, S; Zhan, Q | 1 |
Burns, KH; Rodić, N; Sharma, R; Taube, JM; Zampella, J | 1 |
Cook, M; Lee, JJ; Lian, CG; Mihm, MC; Murphy, GF; Wang, TJ; Xu, S; Zhan, Q | 1 |
Fraitag, S; Hohl, D; Pavlova, O | 1 |
Bamford, M; Joshi, K; Lawes, K; Moosa, F; Pringle, JH; Saldanha, G; Teo, KW | 1 |
Chen, L; Gong, F; Guo, Y; Jin, J; Li, R; Ma, RZ; Niu, Y; Shi, X; Zhang, L; Zhang, X | 1 |
Bosenberg, MW; Micevic, G; Rodić, N; Taube, JM; Theodosakis, N | 1 |
Fang, S; Huff, C; Lee, JE; Shen, J; Song, R; Wan, J; Zhao, H | 1 |
Bresler, SC; Fletcher, CD; Frank, AH; Granter, SR; Hu, NR; Lee, JJ; Lian, CG; Mihm, MC; Murphy, GF; Saw, RP; Scolyer, RA; Vilain, RE; Xu, S | 1 |
Hu, G; Jiang, MJ; Li, FJ; Li, LM; Long, J; Xu, C; Zhang, RH; Zhou, P | 1 |
Ceol, C; Dresser, K; Duncan, LM; Fang, R; Houvras, Y; Hu, D; Hu, Y; Kaiser, UB; Kakavand, H; Khorasani, AJ; Kleffel, S; Larson, A; Lee, CW; Lezcano, C; Lian, BQ; Lian, CG; Mihm, MC; Murphy, GF; Neiswender, J; Schatton, T; Scolyer, RA; Shi, YG; Tan, L; Thompson, JF; Woda, BA; Wu, F; Xu, W; Xu, Y; Yang, Y; Zhan, Q; Zon, LI | 1 |
Besaratinia, A; Pfeifer, GP; You, YH | 1 |
Everett, CA; Finch, M; Hart, IR; Ormerod, EJ | 1 |
Kerbel, RS; Liteplo, RG | 1 |
2 review(s) available for 5-methylcytosine and Melanoma
Article | Year |
---|---|
The role of 5-hydroxymethylcytosine in melanoma.
Topics: 5-Methylcytosine; DNA Methylation; Epigenesis, Genetic; Humans; Melanoma | 2017 |
Mutations induced by ultraviolet light.
Topics: 5-Methylcytosine; Animals; Humans; Melanoma; Mutation; Neoplasms, Radiation-Induced; Pyrimidine Dimers; Skin Neoplasms; Ultraviolet Rays | 2005 |
21 other study(ies) available for 5-methylcytosine and Melanoma
Article | Year |
---|---|
Genome-wide characterization of 5-hydoxymethylcytosine in melanoma reveals major differences with nevus.
Topics: 5-Methylcytosine; 5' Untranslated Regions; Adult; Biomarkers, Tumor; CpG Islands; DNA Methylation; Female; Humans; Male; Melanoma; Middle Aged; Nevus | 2020 |
Epigenetic marker expression is of limited diagnostic utility in spitzoid melanocytic neoplasms.
Topics: 5-Methylcytosine; Biomarkers, Tumor; Diagnosis, Differential; Epigenesis, Genetic; Female; Humans; Male; Melanoma; Nevus, Epithelioid and Spindle Cell; Skin Neoplasms | 2020 |
Global DNA demethylation as an epigenetic marker of human brain metastases.
Topics: 5-Methylcytosine; Biomarkers, Tumor; Brain Neoplasms; Cell Line, Tumor; DNA Demethylation; DNA Methylation; Epigenesis, Genetic; Humans; Melanoma; Prognosis | 2018 |
Diagnostic utility of dual 5-hydroxymethylcytosine/Melan-A immunohistochemistry in differentiating nodal nevus from metastatic melanoma: An effective first-line test for the workup of sentinel lymph node specimen.
Topics: 5-Methylcytosine; Biomarkers, Tumor; Diagnosis, Differential; Humans; Immunohistochemistry; Lymphatic Metastasis; MART-1 Antigen; Melanoma; Melanoma, Cutaneous Malignant; Nevus, Pigmented; Sentinel Lymph Node; Sentinel Lymph Node Biopsy; Skin Neoplasms; Staining and Labeling | 2019 |
Biochemical reconstitution of UV-induced mutational processes.
Topics: 5-Methylcytosine; Cell-Free System; Cytosine; Deamination; DNA Damage; DNA Replication; DNA-Cytosine Methylases; DNA-Directed DNA Polymerase; DNA, Neoplasm; DNA, Single-Stranded; Humans; Melanoma; Models, Genetic; Mutagenesis; Neoplasms, Radiation-Induced; Pyrimidine Dimers; Skin Neoplasms; Transcriptome; Ultraviolet Rays | 2019 |
Loss of 5-hydroxymethylcytosine and ten-eleven translocation 2 protein expression in malignant melanoma.
Topics: 5-Methylcytosine; Biomarkers, Tumor; Cytosine; Dioxygenases; Disease Progression; DNA-Binding Proteins; Epigenomics; Humans; Melanoma; Paraffin Embedding; Proto-Oncogene Proteins; Skin Neoplasms; Translocation, Genetic | 2013 |
5-Hydroxymethylcytosine as a useful marker to differentiate between malignant melanomas and benign melanocytic nevi.
Topics: 5-Methylcytosine; Adult; Aged; Aged, 80 and over; Biomarkers; CpG Islands; Cytosine; DNA Methylation; Epigenesis, Genetic; Female; Humans; Keratinocytes; Male; Melanoma; Middle Aged; Nevus, Epithelioid and Spindle Cell; Nevus, Pigmented; Skin Neoplasms | 2014 |
Transposable hypomethylation is associated with metastatic capacity of primary melanomas.
Topics: 5-Methylcytosine; Adult; CpG Islands; Disease Progression; Disease-Free Survival; DNA Methylation; DNA Transposable Elements; Epigenesis, Genetic; Female; Genetic Predisposition to Disease; Humans; Kaplan-Meier Estimate; Long Interspersed Nucleotide Elements; Male; Melanoma; Middle Aged; Phenotype; Proportional Hazards Models; Risk Factors; Skin Neoplasms; Time Factors; Treatment Outcome; Young Adult | 2013 |
Loss of 5-hydroxymethylcytosine correlates with increasing morphologic dysplasia in melanocytic tumors.
Topics: 5-Methylcytosine; Adult; Aged; Aged, 80 and over; Cytosine; DNA Methylation; Female; Humans; Male; Melanoma; Middle Aged; Nevus; Precancerous Conditions; Skin Neoplasms; Young Adult | 2014 |
5-Hydroxymethylcytosine expression in metastatic melanoma versus nodal nevus in sentinel lymph node biopsies.
Topics: 5-Methylcytosine; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Cytosine; Female; Fluorescent Antibody Technique; Humans; Immunohistochemistry; Lymph Nodes; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Nevus; Sentinel Lymph Node Biopsy; Skin Neoplasms | 2015 |
Diagnostic utility of 5-hydroxymethylcytosine immunohistochemistry in melanocytic proliferations.
Topics: 5-Methylcytosine; Cytosine; Diagnosis, Differential; Humans; Immunohistochemistry; Lymph Nodes; Lymphatic Metastasis; Melanocytes; Melanoma; Nevus, Pigmented; Skin Neoplasms; Tissue Array Analysis | 2015 |
Loss of the epigenetic mark, 5-Hydroxymethylcytosine, correlates with small cell/nevoid subpopulations and assists in microstaging of human melanoma.
Topics: 5-Methylcytosine; Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoma, Small Cell; Cytosine; Epigenomics; Female; Follow-Up Studies; Gene Expression Regulation, Neoplastic; Humans; Immunoenzyme Techniques; Male; Melanoma; Melanoma, Cutaneous Malignant; Middle Aged; Neoplasm Staging; Nevus, Pigmented; Prognosis; Skin Neoplasms; Young Adult | 2015 |
5-Hydroxymethylcytosine Expression in Proliferative Nodules Arising within Congenital Nevi Allows Differentiation from Malignant Melanoma.
Topics: 5-Methylcytosine; Adult; Analysis of Variance; Biopsy, Needle; Cohort Studies; Diagnosis, Differential; Disease Progression; Dysplastic Nevus Syndrome; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Male; Melanoma; Melanoma, Cutaneous Malignant; Nevus, Pigmented; Real-Time Polymerase Chain Reaction; Reproducibility of Results; Retrospective Studies; Skin Neoplasms | 2016 |
5-Hydroxymethylcytosine is an independent predictor of survival in malignant melanoma.
Topics: 5-Methylcytosine; Age Factors; Aged; Female; Humans; Male; Melanoma; Middle Aged; Neoplasm Staging; Prognosis; Retrospective Studies; Skin; Skin Neoplasms; Survival Rate | 2017 |
Epigenetic silencing of TET2 and TET3 induces an EMT-like process in melanoma.
Topics: 5-Methylcytosine; Animals; Azacitidine; Cell Line, Tumor; Chromatin Immunoprecipitation; Decitabine; Dioxygenases; Disease Progression; DNA (Cytosine-5-)-Methyltransferases; DNA Demethylation; DNA Methylation; DNA Methyltransferase 3A; DNA-Binding Proteins; Down-Regulation; Epigenesis, Genetic; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Male; Melanoma; Mice; Mice, Inbred C57BL; Microscopy, Fluorescence; Promoter Regions, Genetic; Proto-Oncogene Proteins; RNA, Small Interfering; Transforming Growth Factor beta1; Xenograft Model Antitumor Assays | 2017 |
Attenuation of genome-wide 5-methylcytosine level is an epigenetic feature of cutaneous malignant melanomas.
Topics: 5-Methylcytosine; Apoptosis; Cell Line, Tumor; DNA Methylation; DNA, Neoplasm; Epigenesis, Genetic; Genome; Humans; Melanoma; Nevus, Pigmented; S-Adenosylmethionine; Skin Neoplasms | 2017 |
Global methylation of blood leukocyte DNA and risk of melanoma.
Topics: 5-Methylcytosine; Aged; Biomarkers, Tumor; Case-Control Studies; DNA Methylation; Female; Genetic Predisposition to Disease; Humans; Leukocytes; Male; Melanoma; Middle Aged; Odds Ratio; Phenotype; Risk Factors; Skin Neoplasms; Skin Pigmentation; Sunlight | 2017 |
5-Hydroxymethylcytosine is a nuclear biomarker to assess biological potential in histologically ambiguous heavily pigmented melanocytic neoplasms.
Topics: 5-Methylcytosine; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Cohort Studies; Female; Fluorescent Antibody Technique; Humans; Immunohistochemistry; Male; Melanoma; Middle Aged; Nevus, Pigmented; Retrospective Studies; Skin Neoplasms; Young Adult | 2017 |
Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma.
Topics: 5-Methylcytosine; Cytosine; Dioxygenases; DNA-Binding Proteins; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Genome-Wide Association Study; Humans; Isocitrate Dehydrogenase; Melanocytes; Melanoma; Nevus; Proto-Oncogene Proteins | 2012 |
DNA methylation levels in human and murine melanoma cell lines of varying metastatic potential.
Topics: 5-Methylcytosine; Animals; Azacitidine; Cell Line; Cytosine; DNA, Neoplasm; Humans; Melanoma; Methylation; Mice; Neoplasm Metastasis | 1986 |
Reduced levels of DNA 5-methylcytosine in metastatic variants of the human melanoma cell line MeWo.
Topics: 5-Methylcytosine; Animals; Cell Line; Chromatography, High Pressure Liquid; Cytosine; DNA; Humans; Hydrolysis; Melanoma; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Metastasis; Uridine | 1987 |